Supplemental material
Journal of Medical Economics
Volume 24, 2021 - Issue 1
Vaccines
Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in Germany
, 
, , , , & show all
Laetitia Gerlierb IQVIA (Global HEOR), Zaventem, Belgiumhttps://orcid.org/0000-0003-0061-0194
https://orcid.org/0000-0003-0061-0194, Martin Eichnerc Epimos GmbH, Dusslingen, Germany;d Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germanyhttps://orcid.org/0000-0002-7377-0191
https://orcid.org/0000-0002-7377-0191, Markus Schwehme ExploSYS GmbH, Leinfelden-Echterdingen, Germanyhttps://orcid.org/0000-0002-8139-1837
https://orcid.org/0000-0002-8139-1837, Sankarasubramanian Rajaramf Seqirus Vaccines Ltd, Maidenhead, UKhttps://orcid.org/0000-0002-8988-7511
https://orcid.org/0000-0002-8988-7511, & show all